Cargando…

Implementation of the therapeutic use of hydroxyurea for sickle cell disease management in resource-constrained settings: a systematic review of adoption, cost and acceptability

OBJECTIVES: Mortality associated with sickle cell disease (SCD) is high in many low- and middle-income countries (LMICs). Hydroxyurea, a medicine to effectively manage SCD, is not widely available in resource-constrained settings. We identified and synthesised the reported implementation outcomes fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryan, Nessa, Dike, Lotanna, Ojo, Temitope, Vieira, Dorice, Nnodu, Obiageli, Gyamfi, Joyce, Peprah, Emmanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654121/ https://www.ncbi.nlm.nih.gov/pubmed/33168553 http://dx.doi.org/10.1136/bmjopen-2020-038685

Ejemplares similares

Evidence-based interventions implemented in low-and middle-income countries for sickle cell disease management: A systematic review of randomized controlled trials
por: Gyamfi, Joyce, et al.
Publicado: (2021)

Implementation science research for the scale-up of evidence-based interventions for sickle cell disease in africa: a commentary
por: Gyamfi, Joyce, et al.
Publicado: (2021)

Barriers to Therapeutic Use of Hydroxyurea for Sickle Cell Disease in Nigeria: A Cross-Sectional Survey
por: Okocha, Emmanuel Chide, et al.
Publicado: (2022)

Implementation of non-insulin-dependent diabetes self-management education (DSME) in LMICs: a systematic review of cost, adoption, acceptability, and fidelity in resource-constrained settings
por: Fitzpatrick, Reilly, et al.
Publicado: (2023)

Development of the ASSESS tool: a comprehenSive tool to Support rEporting and critical appraiSal of qualitative, quantitative, and mixed methods implementation reSearch outcomes
por: Ryan, Nessa, et al.
Publicado: (2022)

Determinants of hydroxyurea use among doctors, nurses and sickle cell disease patients in Nigeria
por: Isa, Hezekiah Alkali, et al.
Publicado: (2022)

The Role of Implementation Science in Advancing Resource Generation for Health Interventions in Low- and Middle-Income Countries
por: Ojo, Temitope, et al.
Publicado: (2021)

Analysis of the 2007–2018 National Health Interview Survey (NHIS): Examining Neurological Complications among Children with Sickle Cell Disease in the United States
por: Peprah, Emmanuel, et al.
Publicado: (2023)

Characterisation of medical conditions of children with sickle cell disease in the USA: findings from the 2007–2018 National Health Interview Survey (NHIS)
por: Gyamfi, Joyce, et al.
Publicado: (2023)

HIV, Tuberculosis, and Food Insecurity in Africa—A Syndemics-Based Scoping Review
por: Ojo, Temitope, et al.
Publicado: (2022)

A Review of the COVID-19 Mental Health Impact in Post-Conflict Settings: Bridging the Mental Health Gap with Case Exemplars from an Implementation Science Lens
por: Noble, Elizabeth, et al.
Publicado: (2023)

Applying the WHO ICD-MM classification system to maternal deaths in a tertiary hospital in Nigeria: A retrospective analysis from 2014–2018
por: Akaba, Godwin O., et al.
Publicado: (2021)

Assessing descriptions of scalability for hypertension control interventions implemented in low-and middle-income countries: A systematic review
por: Gyamfi, Joyce, et al.
Publicado: (2022)

An Evolving HIV Epidemic in the Middle East and North Africa (MENA) Region: A Scoping Review
por: Karbasi, Arvin, et al.
Publicado: (2023)

Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria
por: Chianumba, Reuben Ikechukwu, et al.
Publicado: (2022)

Hydroxyurea Treatment for Sickle Cell Disease
por: Steinberg, Martin H.
Publicado: (2002)

Using a Syndemics Framework to Understand How Substance Use Contributes to Morbidity and Mortality among People Living with HIV in Africa: A Call to Action
por: Peprah, Emmanuel, et al.
Publicado: (2022)

Evidence-based interventions to reduce maternal malnutrition in low and middle-income countries: a systematic review
por: Shenoy, Shivani, et al.
Publicado: (2023)

Implementation of clean cookstove interventions and its effects on blood pressure in low-income and middle-income countries: systematic review
por: Onakomaiya, Deborah, et al.
Publicado: (2019)

Hydroxyurea and sickle cell anemia: effect on quality of life
por: Ballas, Samir K, et al.
Publicado: (2006)

Effective control of sickle cell disease with hydroxyurea therapy
por: Singh, Harminder, et al.
Publicado: (2010)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
por: Torres, Lidiane de Souza, et al.
Publicado: (2012)

Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
por: de Oliveira, Emanuel Almeida Moreira, et al.
Publicado: (2019)

ENHANCE—(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease
por: Creary, Susan, et al.
Publicado: (2016)

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea
por: da Silva, Luiz Bernardino Lima, et al.
Publicado: (2012)

Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"
por: van Beers, Eduard Johannes, et al.
Publicado: (2012)

Emerging Science of Hydroxyurea Therapy for Pediatric Sickle Cell Disease
por: Green, Nancy S., et al.
Publicado: (2013)

Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia
por: Keikhaei, Bijan, et al.
Publicado: (2016)

Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease
por: Wong, Trisha E., et al.
Publicado: (2021)

Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease
por: Pandey, Akancha, et al.
Publicado: (2022)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
por: Kabuyi, Paul Lumbala, et al.
Publicado: (2023)

Using dried blood spot on HemoTypeSC™, a new frontier for newborn screening for sickle cell disease in Nigeria
por: Okeke, Chinwe O., et al.
Publicado: (2022)

Comment on "The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea"
por: Souza, José Carlos, et al.
Publicado: (2012)

Promoting access of hydroxyurea to sickle cell disease individuals: Time to make it an essential medicine
por: Kilonzi, Manase, et al.
Publicado: (2022)

Editorial: Building capacity for sickle cell disease research and healthcare
por: Nembaware, Victoria, et al.
Publicado: (2023)

An Emerging Syndemic of Smoking and Cardiopulmonary Diseases in People Living with HIV in Africa
por: Peprah, Emmanuel, et al.
Publicado: (2021)

Acute chest syndrome and COVID‐19 in hydroxyurea naïve sickle cell disease patient in a low resource setting
por: Mawalla, William Frank, et al.
Publicado: (2022)

Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patients
por: Wonkam, Ambroise, et al.
Publicado: (2015)

Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia
por: Silva, Danilo Grunig Humberto, et al.
Publicado: (2013)

Improving routine outpatient monitoring for patients with sickle-cell disease on hydroxyurea
por: Ward, Joel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fvhbrch6i09l30gnvtah0lnn5i